Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 2

3(37.5%)

8Total

N/A(5)

Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07126314Not ApplicableEnrolling By Invitation

Critical Appraisals at Play

Role: lead

NCT07070401Not ApplicableRecruiting

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

Role: lead

NCT06547294Not ApplicableSuspended

Does a Novel Needle Over Catheter Device Improve First Pass Success and Decrease Complications

Role: lead

NCT05505799Not ApplicableActive Not Recruiting

Community Medical Center, Continuous Quality Improvement Project, Rapid Sequence Intubation

Role: lead

NCT04614610Phase 2Unknown

Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis

Role: lead

NCT05616065Not ApplicableCompleted

Bias Reduction in Academic Recruitment

Role: lead

NCT03825510Phase 2Completed

Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect

Role: collaborator

NCT03422159Phase 2Completed

Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in Sepsis.

Role: lead

All 8 trials loaded